Antibiotic Allergy

Immunology and Allergy Clinics of North America

Volumn 34, Issue 3, 2014, Pages 489-506

  Romano, Antonino ^a   Warrington, Richard ^b  

^a CATHOLIC UNIVERSITY   (Italy)

^b UNIVERSITY OF MANITOBA   (Canada)

Author keywords

Allergy; Antibiotics; Drug; Hypersensitivity; Immediate; Non lactam; Nonimmediate; lactam

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMOXICILLIN; BETA LACTAM ANTIBIOTIC; CARBAPENEM DERIVATIVE; CLAVULANIC ACID; CLINDAMYCIN; IMMUNOGLOBULIN E; MACROLIDE; MONOBACTAM DERIVATIVE; PENICILLIN G; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMYCIN; SULFONAMIDE; VANCOMYCIN; ANTIINFECTIVE AGENT;

ACUTE GENERALIZED EXANTHEMATOUS PUSTULOSIS; ANAPHYLACTIC SHOCK; ANAPHYLAXIS; ANGIONEUROTIC EDEMA; ANTIBIOTIC AGENT ALLERGY; ANTIGEN PRESENTATION; BRONCHOSPASM; CLINICAL FEATURE; CLINICAL PROTOCOL; CONJUNCTIVITIS; CYSTIC FIBROSIS; DIAGNOSTIC TEST; DRESS SYNDROME; DRUG HYPERSENSITIVITY; GASTROINTESTINAL SYMPTOM; GENETIC ASSOCIATION; HEPATITIS; HLA SYSTEM; HUMAN; IMMUNE RESPONSE; IMMUNOGENICITY; INTERSTITIAL NEPHRITIS; PATCH TEST; PATHOGENESIS; PATIENT CARE; PENICILLIN ALLERGY; PNEUMONIA; PRACTICE GUIDELINE; PREDICTIVE VALUE; PRIORITY JOURNAL; RADIOIMMUNOASSAY; REVIEW; RHINITIS; SKIN TEST; STEVENS JOHNSON SYNDROME; T LYMPHOCYTE; TOXIC EPIDERMAL NECROLYSIS; URTICARIA; VASCULITIS; ALGORITHM; CLASSIFICATION; RISK FACTOR;

ALGORITHMS; ANTI-BACTERIAL AGENTS; DRUG HYPERSENSITIVITY; HUMANS; RISK FACTORS;

EID: 84904101035     PISSN: 08898561     EISSN: 15578607     Source Type: Journal    
DOI: 10.1016/j.iac.2014.03.003     Document Type: Review

References (142)

1. Pichler W., Naisbitt D., Park B. Immune pathomechanism of drug hypersensitivity reactions. JAllergy Clin Immunol 2011, 127:S74-S81.
2. Jenkins R., Yaseen F., Monshi M., et al. beta-Lactam antibiotics form distinct haptenic structures on albumin and activate drug-specific T-lymphocyte responses in multiallergic patients with cystic fibrosis. Chem Res Toxicol 2013, 26:963-975.
3. Meng X., Jenkins R., Berry N., et al. Direct evidence for the formation of diastereoisomeric benzylpenicilloyl haptens from benzylpenicillin and benzylpenicillenic acid in patients. JPharmacol Exp Ther 2011, 338:841-849.
4. Levine B. Immunologic mechanisms of penicillin allergy. A haptenic model system for the study of allergic diseases of man. NEngl J Med 1966, 275:1115-1125.
5. Pichler W.J. Immune mechanism of drug hypersensitivity. Immunol Allergy Clin North Am 2004, 24:373-397. v-vi.
6. Perez-Inestrosa E., Suau R., Montanez M., et al. Cephalosporin chemical reactivity and its immunological implications. Curr Opin Allergy Clin Immunol 2005, 5:323-330.
7. Elsheikh A., Castrejon L., Lavergne S., et al. Enhanced antigenicity leads to altered immunogenicity in sulfamethoxazole-hypersensitive patients with cystic fibrosis. JAllergy Clin Immunol 2011, 127:1543-1551.e3.
8. Elsheikh A., Lavergne S., Castrejon J., et al. Drug antigenicity, immunogenicity, and costimulatory signaling: evidence for formation of a functional antigen through immune cell metabolism. JImmunol 2010, 185:6448-6460.
9. El-Ghaiesh S., Monshi M., Whitaker P., et al. Characterization of the antigen specificity of T-cell clones from piperacillin-hypersensitive patients with cystic fibrosis. JPharmacol Exp Ther 2012, 341:597-610.
10. Zaheer-ul-Haq, Khan W. Molecular and structural determinants of adamantyl susceptibility to HLA-DRs allelic variants: an in silico approach to understand the mechanism of MLEs. JComput Aided Mol Des 2011, 25:81-101.
11. Pichler W. Pharmacological interaction of drugs with antigen-specific immune receptors: the p-i concept. Curr Opin Allergy Clin Immunol 2002, 2:301-305.
12. Posadas S., Pichler W. Delayed drug hypersensitivity reactions-new concepts. Clin Exp Allergy 2007, 37:989-999.
13. Illing P., Vivian J., Dudek N., et al. Immune self-reactivity triggered by drug-modified HLA-peptide repertoire. Nature 2012, 486:554-558.
14. Adam J., Eriksson K., Schnyder B., et al. Avidity determines T-cell reactivity in abacavir hypersensitivity. Eur J Immunol 2012, 42(7):1706-1716.
15. Solensky R. Allergy to beta-lactam antibiotics. JAllergy Clin Immunol 2012, 130:1442-2.e5.
16. Macy E., Schatz M., Lin C., et al. The falling rate of positive penicillin skin tests from 1995 to 2007. Perm J 2009, 13:12-18.
17. Gomes E., Demoly P. Epidemiology of hypersensitivity drug reactions. Curr Opin Allergy Clin Immunol 2005, 5:309-316.
18. Smyth R., Gargon E., Kirkham J., et al. Adverse drug reactions in children-a systematic review. PLoS One 2012, 7:e24061.
19. Rawlins M.D., Thompson J.W. Pathogenesis of adverse drug reactions. Textbook of Adverse Drug Reactions 1977, 832-836. Oxford University Press, New York. D.M. Davis (Ed.).
20. Johansson S., Bieber T., Dahl R., et al. Revised nomenclature for allergy for global use: report of the Nomenclature Review Committee of the World Allergy Organization, October 2003. JAllergy Clin Immunol 2004, 113:832-836.
21. Romano A., Torres M., Castells M., et al. Diagnosis and management of drug hypersensitivity reactions. JAllergy Clin Immunol 2011, 127:S67-S73.
22. Pichler W. Delayed drug hypersensitivity reactions. Ann Intern Med 2003, 139:683-693.
23. Romano A., Blanca M., Torres M., et al. Diagnosis of nonimmediate reactions to beta-lactam antibiotics. Allergy 2004, 59:1153-1160.
24. Demoly P., Bousquet J. Drug allergy diagnosis work up. Allergy 2002, 57(Suppl 72):37-40.
25. Gomez E., Blanca-Lopez N., Salas M., et al. Induction of accelerated reactions to amoxicillin by T-cell effector mechanisms. Ann Allergy Asthma Immunol 2013, 110:267-273.
26. Bircher A., Scherer K. Delayed cutaneous manifestations of drug hypersensitivity. Med Clin North Am 2010, 94:711-725. x.
27. Bircher A., Scherer Hofmeier K. Drug hypersensitivity reactions: inconsistency in the use of the classification of immediate and nonimmediate reactions. JAllergy Clin Immunol 2012, 129:263-264. [author reply: 255-6].
28. Chang C., Mahmood M., Teuber S., et al. Overview of penicillin allergy. Clin Rev Allergy Immunol 2012, 43:84-97.
29. Warrington R., Silviu-Dan F., Magro C. Accelerated cell-mediated immune reactions in penicillin allergy. JAllergy Clin Immunol 1993, 92:626-628.
30. Adkinson N.J. Risk factors for drug allergy. JAllergy Clin Immunol 1984, 74:567-572.
31. Pirmohamed M., Park B.K. HIV and drug allergy. Curr Opin Allergy Clin Immunol 2001, 1:311-316.
32. Jappe U. Amoxicillin-induced exanthema in patients with infectious mononucleosis: allergy or transient immunostimulation?. Allergy 2007, 62:1474-1475.
33. Renn C.N., Straff W., Dorfmuller A., et al. Amoxicillin-induced exanthema in young adults with infectious mononucleosis: demonstration of drug-specific lymphocyte reactivity. Br J Dermatol 2002, 147:1166-1170.
34. Blanca M., Romano A., Torres M., et al. Update on the evaluation of hypersensitivity reactions to betalactams. Allergy 2009, 64:183-193.
35. Brockow K., Romano A., Blanca M., et al. General considerations for skin test procedures in the diagnosis of drug hypersensitivity. Allergy 2002, 57:45-51.
36. Solensky R., Khan D.A. Drug allergy: an updated practice parameter. Ann Allergy Asthma Immunol 2010, 105:259-273.
37. Macy E., Richter P., Falkoff R., et al. Skin testing with penicilloate and penilloate prepared by an improved method: amoxicillin oral challenge in patients with negative skin test responses to penicillin reagents. JAllergy Clin Immunol 1997, 100:586-591.
38. Macy E. The clinical evaluation of penicillin allergy: what is necessary, sufficient and safe given the materials currently available?. Clin Exp Allergy 2011, 41:1498-1501.
39. Macy E., Ngor E. Safely diagnosing clinically significant penicillin allergy using only penicilloyl-poly-lysine, penicillin, and oral amoxicillin. JAllergy Clin Immunol 2013, 1(3):258-263.
40. Elzagallaai A.A., Koren G., Bend J.R., et al. Invitro testing for hypersensitivity-mediated adverse drug reactions: challenges and future directions. Clin Pharmacol Ther 2011, 90:455-460.
41. Torres M., Padial A., Mayorga C., et al. The diagnostic interpretation of basophil activation test in immediate allergic reactions to betalactams. Clin Exp Allergy 2004, 34:1768-1775.
42. Macy E., Goldberg B., Poon K. Use of commercial anti-penicillin IgE fluorometric enzyme immunoassays to diagnose penicillin allergy. Ann Allergy Asthma Immunol 2010, 105:136-141.
43. Barbaud A., Collet E., Milpied B., et al. Amulticentre study to determine the value and safety of drug patch tests for the three main classes of severe cutaneous adverse drug reactions. Br J Dermatol 2013, 168:555-562.
44. Pichler W., Tilch J. The lymphocyte transformation test in the diagnosis of drug hypersensitivity. Allergy 2004, 59:809-820.
45. Warrington R.J., Tse K.S. Lymphocyte transformation studies in drug hypersensitivity. Can Med Assoc J 1979, 120:1089-1094.
46. Warrington R., Sauder P., McPhillips S. Lymphocyte transformation studies in suspected hypersensitivity to trimethoprim-sulphamethoxazole. Clin Allergy 1983, 13:235-240.
47. Tanvarasethee B., Buranapraditkun S., Klaewsongkram J. The potential of using enzyme-linked immunospot to diagnose cephalosporin-induced maculopapular exanthems. Acta Derm Venereol 2013, 93:66-69.
48. Rozieres A., Hennino A., Rodet K., et al. Detection and quantification of drug-specific T cells in penicillin allergy. Allergy 2009, 64:534-542.
49. Johansson S.G., Adedoyin J., van Hage M., et al. False-positive penicillin immunoassay: an unnoticed common problem. JAllergy Clin Immunol 2013, 132:235-237.
50. Aberer W., Bircher A., Romano A., et al. Drug provocation testing in the diagnosis of drug hypersensitivity reactions: general considerations. Allergy 2003, 58:854-863.
51. Messaad D., Sahla H., Benahmed S., et al. Drug provocation tests in patients with a history suggesting an immediate drug hypersensitivity reaction. Ann Intern Med 2004, 140:1001-1006.
52. Macy E. Penicillin allergy might not be very common in subjects with cephalosporin allergy. JAllergy Clin Immunol 2011, 127:1638. [author reply: 1638-9].
53. Warrington R.J., Simons F.E., Ho H.W., et al. Diagnosis of penicillin allergy by skin testing: the Manitoba experience. Can Med Assoc J 1978, 118:787-791.
54. Blanca M., Mayorga C., Torres M., et al. Side-chain-specific reactions to betalactams: 14 years later. Clin Exp Allergy 2002, 32:192-197.
55. Torres M., Blanca M. The complex clinical picture of beta-lactam hypersensitivity: penicillins, cephalosporins, monobactams, carbapenems, and clavams. Med Clin North Am 2010, 94:805-820. xii.
56. Solley G., Gleich G., Van Dellen R. Penicillin allergy: clinical experience with a battery of skin-test reagents. JAllergy Clin Immunol 1982, 69:238-244.
57. Gadde J., Spence M., Wheeler B., et al. Clinical experience with penicillin skin testing in a large inner-city STD clinic. JAMA 1993, 270:2456-2463.
58. Lin E., Saxon A., Riedl M. Penicillin allergy: value of including amoxicillin as a determinant in penicillin skin testing. Int Arch Allergy Immunol 2010, 152:313-318.
59. Bousquet P., Co-Minh H., Arnoux B., et al. Importance of mixture of minor determinants and benzylpenicilloyl poly-L-lysine skin testing in the diagnosis of beta-lactam allergy. JAllergy Clin Immunol 2005, 115:1314-1316.
60. Torres M.J., Blanca M. The contribution of major and minor determinants from benzylpenicillin to the diagnosis of immediate allergy to beta-lactams. JAllergy Clin Immunol 2006, 117:220-221. [author reply: 221].
61. Romano A., Gaeta F., Valluzzi R., et al. The very limited usefulness of skin testing with penicilloyl-polylysine and the minor determinant mixture in evaluating nonimmediate reactions to penicillins. Allergy 2010, 65:1104-1107.
62. Torres M., Mayorga C., Leyva L., et al. Controlled administration of penicillin to patients with a positive history but negative skin and specific serum IgE tests. Clin Exp Allergy 2002, 32:270-276.
63. Torres M.J., Romano A., Mayorga C., et al. Diagnostic evaluation of a large group of patients with immediate allergy to penicillins: the role of skin testing. Allergy 2001, 56:850-856.
64. Montanez M., Torres M., Perez-Inestrosa E., et al. Clarification concerning amoxicillin skin testing. JAllergy Clin Immunol 2011, 128:685. [author reply: 686].
65. Macy E., Ngor E. Recommendations for the management of beta-lactam intolerance. Clin Rev Allergy Immunol 2013, [Epub ahead of print].
66. Torres M., Ariza A., Mayorga C., et al. Clavulanic acid can be the component in amoxicillin-clavulanic acid responsible for immediate hypersensitivity reactions. JAllergy Clin Immunol 2010, 125:502-505.e2.
67. Romano A., Gueant-Rodriguez R., Viola M., et al. Diagnosing immediate reactions to cephalosporins. Clin Exp Allergy 2005, 35:1234-1242.
68. Yoon S., Park S., Kim S., et al. Validation of the cephalosporin intradermal skin test for predicting immediate hypersensitivity: a prospective study with drug challenge. Allergy 2013, 68:938-944.
69. Dickson S., Salazar K. Diagnosis and management of immediate hypersensitivity reactions to cephalosporins. Clin Rev Allergy Immunol 2013, 45:131-142.
70. Somech R., Weber E.A., Lavi S. Evaluation of immediate allergic reactions to cephalosporins in non-penicillin-allergic patients. Int Arch Allergy Immunol 2009, 150:205-209.
71. Antunez C., Blanca-Lopez N., Torres M.J., et al. Immediate allergic reactions to cephalosporins: evaluation of cross-reactivity with a panel of penicillins and cephalosporins. JAllergy Clin Immunol 2006, 117:404-410.
72. Romano A., Gaeta F., Valluzzi R., et al. Diagnosing hypersensitivity reactions to cephalosporins in children. Pediatrics 2008, 122:521-527.
73. Garcia Nunez I., Barasona Villarejo M.J., Algaba Marmol M.A., et al. Diagnosis of patients with immediate hypersensitivity to beta-lactams using retest. JInvestig Allergol Clin Immunol 2012, 22:41-47.
74. Parker P.J., Parrinello J.T., Condemi J.J., et al. Penicillin resensitization among hospitalized patients. JAllergy Clin Immunol 1991, 88:213-217.
75. Pichichero M., Pichichero D. Diagnosis of penicillin, amoxicillin, and cephalosporin allergy: reliability of examination assessed by skin testing and oral challenge. JPediatr 1998, 132:137-143.
76. Torres M.J., Sanchez-Sabate E., Alvarez J., et al. Skin test evaluation in nonimmediate allergic reactions to penicillins. Allergy 2004, 59:219-224.
77. Goldberg A., Confino-Cohen R. Skin testing and oral penicillin challenge in patients with a history of remote penicillin allergy. Ann Allergy Asthma Immunol 2008, 100:37-43.
78. Solensky R., Earl H., Gruchalla R. Lack of penicillin resensitization in patients with a history of penicillin allergy after receiving repeated penicillin courses. Arch Intern Med 2002, 162:822-826.
79. Macy E., Burchette R. Oral antibiotic adverse reactions after penicillin skin testing: multi-year follow-up. Allergy 2002, 57:1151-1158.
80. Torres M., Blanca M., Fernandez J., et al. Diagnosis of immediate allergic reactions to beta-lactam antibiotics. Allergy 2003, 58:961-972.
81. Co Minh H., Bousquet P., Fontaine C., et al. Systemic reactions during skin tests with beta-lactams: a risk factor analysis. JAllergy Clin Immunol 2006, 177:466-468.
82. Atanaskovic-Markovic M., Velickovic T., Gavrovic-Jankulovic M., et al. Immediate allergic reactions to cephalosporins and penicillins and their cross-reactivity in children. Pediatr Allergy Immunol 2005, 16:341-347.
83. Ponvert C., Perrin Y., Bados-Albiero A., et al. Allergy to betalactam antibiotics in children: results of a 20-year study based on clinical history, skin and challenge tests. Pediatr Allergy Immunol 2011, 22:411-418.
84. Romano A., Gaeta F., Valluzzi R., et al. Diagnosing nonimmediate reactions to cephalosporins. JAllergy Clin Immunol 2012, 129:1166-1169.
85. Borch J., Bindslev-Jensen C. Full-course drug challenge test in the diagnosis of delayed allergic reactions to penicillin. Int Arch Allergy Immunol 2011, 155:271-274.
86. Demoly P., Romano A., Botelho C., et al. Determining the negative predictive value of provocation tests with beta-lactams. Allergy 2010, 65:327-332.
87. Hjortlund J., Mortz C., Skov P., et al. Diagnosis of penicillin allergy revisited: the value of case history, skin testing, specific IgE and prolonged challenge. Allergy 2013, 68:1057-1064.
88. Iglesias Cadarso A., Saez Jimenez S., Vidal Pan C., et al. Aztreonam-induced anaphylaxis. Lancet 1990, 336:746-747.
89. de la Fuente Prieto R., Armentia Medina A., Sanchez Palla P., et al. Urticaria caused by sensitization to aztreonam. Allergy 1993, 48:634-636.
90. Perez Pimiento A., Gomez Martinez M., Minguez Mena A., et al. Aztreonam and ceftazidime: evidence of invivo cross allergenicity. Allergy 1998, 53:624-625.
91. Chen Z., Baur X., Kutscha-Lissberg F., et al. IgE-mediated anaphylactic reaction to imipenem. Allergy 2000, 55:92-93.
92. Romano A., Gueant-Rodriguez R., Viola M., et al. Cross-reactivity among drugs: clinical problems. Toxicology 2005, 209:169-179.
93. Romano A., Viola M., Gueant-Rodriguez R., et al. Imipenem in patients with immediate hypersensitivity to penicillins. NEngl J Med 2006, 354:2835-2837.
94. Romano A., Viola M., Gueant-Rodriguez R., et al. Brief communication: tolerability of meropenem in patients with IgE-mediated hypersensitivity to penicillins. Ann Intern Med 2007, 146:266-269.
95. Romano A., Gaeta F., Valluzzi R., et al. IgE-mediated hypersensitivity to cephalosporins: cross-reactivity and tolerability of penicillins, monobactams, and carbapenems. JAllergy Clin Immunol 2010, 126:994-999.
96. Pichichero M.E., Casey J.R. Safe use of selected cephalosporins in penicillin-allergic patients: a meta-analysis. Otolaryngol Head Neck Surg 2007, 136:340-347.
97. Atanaskovic-Markovic M. Educational case series: beta-lactam allergy and cross-reactivity. Pediatr Allergy Immunol 2011, 22:770-775.
98. Romano A., Gueant-Rodriguez R., Viola M., et al. Cross-reactivity and tolerability of cephalosporins in patients with immediate hypersensitivity to penicillins. Ann Intern Med 2004, 141:16-22.
99. Blanca-Lopez N., Andreu I., Torres Jaen M. Hypersensitivity reactions to quinolones. Curr Opin Allergy Clin Immunol 2011, 11:285-291.
100. Blanca-Lopez N., Ariza A., Dona I., et al. Hypersensitivity reactions to fluoroquinolones: analysis of the factors involved. Clin Exp Allergy 2013, 43:560-567.
101. Manfredi M., Severino M., Testi S., et al. Detection of specific IgE to quinolones. JAllergy Clin Immunol 2004, 113:155-160.
102. Aranda A., Mayorga C., Ariza A., et al. Invitro evaluation of IgE-mediated hypersensitivity reactions to quinolones. Allergy 2011, 66:247-254.
103. Ball P. Adverse drug reactions: implications for the development of fluoroquinolones. JAntimicrob Chemother 2003, 51(Suppl 1):21-27.
104. Iannini P., Mandell L., Felmingham J., et al. Adverse cutaneous reactions and drugs: a focus on antimicrobials. JChemother 2006, 18:127-139.
105. Schmid D., Depta J., Pichler W. Tcell-mediated hypersensitivity to quinolones: mechanisms and cross-reactivity. Clin Exp Allergy 2006, 36:59-69.
106. Seitz C., Brocker E., Trautmann A. Diagnostic testing in suspected fluoroquinolone hypersensitivity. Clin Exp Allergy 2009, 39:1738-1745.
107. Araujo L., Demoly P. Macrolides allergy. Curr Pharm Des 2008, 14:2840-2862.
108. San Pedro de Saenz B., Gomez A., Quiralte J., et al. FDE to macrolides. Allergy 2002, 57:55-56.
109. Benahmed S., Scaramuzza C., Messaad D., et al. The accuracy of the diagnosis of suspected macrolide antibiotic hypersensitivity: results of a single-blinded trial. Allergy 2004, 59:1130-1133.
110. Mori F., Barni S., Pucci N., et al. Sensitivity and specificity of skin tests in the diagnosis of clarithromycin allergy. Ann Allergy Asthma Immunol 2010, 104:417-419.
111. Pascual C., Crespo J., Quiralte J., et al. Invitro detection of specific IgE antibodies to erythromycin. JAllergy Clin Immunol 1995, 95:668-671.
112. Kruppa A., Scharffetter-Kochanek K., Krieg T., et al. Immediate reaction to roxithromycin and prick test cross-sensitization to erythromycin and clarithromycin. Dermatology 1998, 196:335-336.
113. Swamy N., Laurie S., Ruiz-Huidobro E., et al. Successful clarithromycin desensitization in a multiple macrolide-allergic patient. Ann Allergy Asthma Immunol 2010, 105:489-490.
114. Milkovic-Kraus S., Macan J., Kanceljak-Macan B. Occupational allergic contact dermatitis from azithromycin in pharmaceutical workers: a case series. Contact Dermatitis 2007, 56:99-102.
115. Seitz C., Brocker E., Trautmann A. Suspicion of macrolide allergy after treatment of infectious diseases including Helicobacter pylori: results of allergological testing. Allergol Immunopathol (Madr) 2011, 39:193-199.
116. Zawodniak A., Lochmatter P., Beeler A., et al. Cross-reactivity in drug hypersensitivity reactions to sulfasalazine and sulfamethoxazole. Int Arch Allergy Immunol 2010, 153:152-156.
117. Schnyder B., Pichler W. Allergy to sulfonamides. JAllergy Clin Immunol 2013, 131:256-257.e1-5.
118. Gruchalla R. 10. Drug allergy. JAllergy Clin Immunol 2003, 111:S548-S559.
119. van der Klauw M., Wilson J., Stricker B. Drug-associated anaphylaxis: 20 years of reporting in The Netherlands (1974-1994) and review of the literature. Clin Exp Allergy 1996, 26:1355-1363.
120. Empedrad R., Darter A., Earl H., et al. Nonirritating intradermal skin test concentrations for commonly prescribed antibiotics. JAllergy Clin Immunol 2003, 112:629-630.
121. Gruchalla R., Sullivan T. Detection of human IgE to sulfamethoxazole by skin testing with sulfamethoxazoyl-poly-L-tyrosine. JAllergy Clin Immunol 1991, 88:784-792.
122. Shapiro L., Knowles S., Weber E., et al. Safety of celecoxib in individuals allergic to sulfonamide: a pilot study. Drug Saf 2003, 26:187-195.
123. Kavadas F.D., Kasprzak A., Atkinson A.R. Antibiotic skin testing accompanied by provocative challenges in children is a useful clinical tool. Allergy Asthma Clin Immunol 2013, 9:22.
124. Tornero P., De Barrio M., Baeza M., et al. Cross-reactivity among p-amino group compounds in sulfonamide fixed drug eruption: diagnostic value of patch testing. Contact Dermatitis 2004, 51:57-62.
125. Gilbert D.N. Mandell, Douglas and Bennett's Principles and Practice of Infectious Diseases 2010, Churchill Livingstone Elsevier, Philadelphia.
126. Romano A., Viola M., Di Fonso M., et al. Anaphylaxis to streptomycin. Allergy 2002, 57:1087-1088.
127. Connolly M., McAdoo J., Bourke J. Gentamicin-induced anaphylaxis. Ir J Med Sci 2007, 176:317-318.
128. Dyck E., Vadas P. Anaphylaxis to topical bacitracin. Allergy 1997, 52:870-871.
129. Sharif S., Goldberg B. Detection of IgE antibodies to bacitracin using a commercially available streptavidin-linked solid phase in a patient with anaphylaxis to triple antibiotic ointment. Ann Allergy Asthma Immunol 2007, 98:563-566.
130. Gall R., Blakley B., Warrington R., et al. Intraoperative anaphylactic shock from bacitracin nasal packing after septorhinoplasty. Anesthesiology 1999, 91:1545-1547.
131. Lee Y., Cho Y., Han M. Anaphylaxis due to ribostamycin. Allergy 2004, 59:1134-1135.
132. Gehrig K., Warshaw E. Allergic contact dermatitis to topical antibiotics: epidemiology, responsible allergens, and management. JAm Acad Dermatol 2008, 58:1-21.
133. Liippo J., Lammintausta K. Positive patch test reactions to gentamicin show sensitization to aminoglycosides from topical therapies, bone cements, and from systemic medication. Contact Dermatitis 2008, 59:268-272.
134. Notman M., Phillips E., Knowles S., et al. Clindamycin skin testing has limited diagnostic potential. Contact Dermatitis 2005, 53:335-338.
135. Seitz C., Brocker E., Trautmann A. Allergy diagnostic testing in clindamycin-induced skin reactions. Int Arch Allergy Immunol 2009, 149:246-250.
136. Scala E., Giani M., Pirrotta L., et al. Multiple drug allergy syndrome: severe anaphylactic reaction due to topical rifamycin SV in a patient with hypersensitivity to ciprofloxacin. Int J Dermatol 2001, 40:603-604.
137. Ebo D., Verheecke G., Bridts C., et al. Perioperative anaphylaxis from locally applied rifamycin SV and latex. Br J Anaesth 2006, 96:738-741.
138. Buergin S., Scherer K., Hausermann P., et al. Immediate hypersensitivity to rifampicin in 3 patients: diagnostic procedures and induction of clinical tolerance. Int Arch Allergy Immunol 2006, 140:20-26.
139. Cardot E., Tillie-Leblond I., Jeannin P., et al. Anaphylactic reaction to local administration of rifamycin SV. JAllergy Clin Immunol 1995, 95:1-7.
140. Erel F., Karaayvaz M., Deveci M., et al. Severe anaphylaxis from rifamycin SV. Ann Allergy Asthma Immunol 1998, 81:257-260.
141. Anne' S., Middleton E.J., Reisman R. Vancomycin anaphylaxis and successful desensitization. Ann Allergy 1994, 73:402-404.
142. Bernedo N., Gonzalez I., Gastaminza G., et al. Positive patch test in vancomycin allergy. Contact Dermatitis 2001, 45:43.